Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acclerated calcium nephrolithiasis

F L Coe, J H Parks, A L Strauss

    JAMA
    |August 22, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Patients with severe calcium nephrolithiasis (kidney stones) form stones rapidly but have common causes and respond well to standard treatments. Management for severe and common kidney stone disease is the same.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.

    Kidney international·2007
    Same author

    Urine calcium excretion predicts bone loss in idiopathic hypercalciuria.

    Kidney international·2006
    Same author

    Renal crystal deposits and histopathology in patients with cystine stones.

    Kidney international·2006
    Same author

    Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.

    Kidney international·2006
    Same author

    Urinary cystine excretion and capacity in patients with cystinuria.

    Kidney international·2006
    Same author

    Patient adherence to long-term medical treatment of kidney stones.

    The Journal of urology·2001
    Same journal

    WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

    JAMA·2026
    Same journal

    FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

    JAMA·2026
    Same journal

    HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

    JAMA·2026
    Same journal

    US Dietary Supplement Use Increasing, Especially in Older Adults.

    JAMA·2026
    Same journal

    Heat Stress From Climate Change Surges Globally.

    JAMA·2026
    Same journal

    Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

    JAMA·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Urology
    • Mineral Metabolism

    Background:

    • Calcium nephrolithiasis is a common condition.
    • A subset of patients exhibits unusually severe stone formation.
    • Understanding severe calcium nephrolithiasis is crucial for effective patient management.

    Purpose of the Study:

    • To characterize patients with extremely active calcium nephrolithiasis.
    • To determine if severe calcium nephrolithiasis has unique metabolic causes.
    • To assess treatment response in patients with severe stone disease.

    Main Methods:

    • Retrospective analysis of 674 patients with calcium nephrolithiasis.
    • Identification of a subgroup with accelerated stone formation.
    • Evaluation of metabolic profiles and treatment outcomes.

    Related Experiment Videos

    Main Results:

    • 78 out of 674 patients (11.6%) had severe stone disease.
    • Severe stone formers averaged 22 stones per patient and 172 stones per 100 patient-years.
    • These patients shared common metabolic stone causes and responded well to treatment.

    Conclusions:

    • Extremely active calcium nephrolithiasis is associated with common metabolic abnormalities.
    • Patients with severe calcium nephrolithiasis should be managed similarly to those with less active disease.
    • Standard diagnostic and therapeutic approaches are effective for severe calcium nephrolithiasis.